Study of CVN424 in Healthy Subjects

NCT03657030 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CVN424
DRUG: Placebo

Sponsor

Cerevance Beta, Inc.